收藏切换
International experience of gene therapy drug payment mode and its enlightenment to China
收藏切换
Ni YUAN1, Guangsheng LIANG2, Hanyu CHANG3, Meiqi WANG1, Xiaoyan GUAN1, Jun HU4
World Clinical Drug | 2022, 43(2) : 115 - 123
Less
收藏切换
World Clinical Drug | 2022, 43(2): 115-123
• Topic •
International experience of gene therapy drug payment mode and its enlightenment to China
Full
Ni YUAN1, Guangsheng LIANG2, Hanyu CHANG3, Meiqi WANG1, Xiaoyan GUAN1, Jun HU4
Affiliations
  • 1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China
  • 2.China Welfare Association International Peace Maternal and Child Health Hospital, Shanghai 200030, China
  • 3.Department of Medical Insurance Administration, The First Hospital of Lanzhou University, Lanzhou 730013, Gansu Province, China
  • 4.Shanghai Adverse Reaction Monitoring Center for Drugs and Medical Devices, Shanghai 200040, China
Published: 2022-02-10 doi: 10.13683/j.wph.2022.02.002
Outline
收藏切换

Gene therapy, as a new type of treatment, has been applied to rare disease and other difficult medical problems, bringing hopes to patients with rare disease. However, three major challenges including difficulty in evidence generating or data collection, value evaluation (including pricing and budget impact analysis) and difficulties in payment and reimbursement. Therefore, formulating a reasonable payment was essential to protect the health of patients and improve the accessibility of gene therapy. Taking gene therapy drugs for rare disease as an example, this article summarized the current payment models and some practices in developed countries, in order to discuss how to pay for expensive gene therapy drugs within the limited budget constraints.

rare disease  /  gene therapy  /  payment and reimbursement
袁妮, 梁广盛, 常翰玉, 王美琪, 关晓岩, 胡骏. 基因治疗药物支付方式的国际经验及对我国的启示. 世界临床药物, 2022 , 43 (2) : 115 -123 . DOI: 10.13683/j.wph.2022.02.002
Ni YUAN, Guangsheng LIANG, Hanyu CHANG, Meiqi WANG, Xiaoyan GUAN, Jun HU. International experience of gene therapy drug payment mode and its enlightenment to China[J]. World Clinical Drug, 2022 , 43 (2) : 115 -123 . DOI: 10.13683/j.wph.2022.02.002
Year 2022 volume 43 Issue 2
12
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.02.002
  • Receive Date:2021-11-04
  • Online Date:2026-11-19
  • Published:2022-02-10
Article Data
Affiliations
History
  • Received:2021-11-04
Funding
Affiliations
    1.School of Public Health, Dalian Medical University, Dalian 116044, Liaoning Province, China
    2.China Welfare Association International Peace Maternal and Child Health Hospital, Shanghai 200030, China
    3.Department of Medical Insurance Administration, The First Hospital of Lanzhou University, Lanzhou 730013, Gansu Province, China
    4.Shanghai Adverse Reaction Monitoring Center for Drugs and Medical Devices, Shanghai 200040, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.02.002
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT